cc.\*:("002A31D01")
Results 1 to 25 of 12241
Selection :
Meeting the regulatory requirements for pharmaceutical production of recombinant DNA derived productsWERNER, R. G; LANGLOUIS-GAU, H.Arzneimittel-Forschung. 1989, Vol 39, Num 1, pp 108-111, issn 0004-4172Article
An electrochemical immunoassay for prostatic acid phosphatase incorporating enzyme amplificationCARDOSI, M. F; BIRCH, S. W; STANLEY, C. J et al.International biotechnology laboratory. 1989, Vol 7, Num 2, pp 8-17, issn 0888-7225, 8 p.Article
Secretion of peptides from E. coli: a production system for the pharmaceutical industryJOSEPHSON, S; BISHOP, R.Trends in biotechnology (Regular ed.). 1988, Vol 6, Num 9, pp 218-224, issn 0167-7799Article
Consideration of proteins and peptides produced by new technology for use as therapeutic agentsLIU, D. T; GOLDMAN, N; GATES, F. III et al.A.C.S. symposium series. 1988, Num 362, pp 162-171, issn 0097-6156Conference Paper
The use of DNA probes to diagnose viral infectionsTAUB, F. E; GRILLO, S. L; BRUNS, C. M et al.Developments in industrial microbiology. 1988, Vol 29, pp 119-129, issn 0070-4563, suppl. 3Conference Paper
Enzyme amplification in diagnosticsBATES, D. L.Trends in biotechnology (Library edition). 1987, Vol 5, Num 7, pp 204-209, issn 0167-9430Article
Homogeneous enzyme-linked competitive binding assays using natural binding proteins: a biological gateTSALTA, C. D; BACHAS, L. G; DAUNERT, S et al.BioTechniques. 1987, Vol 5, Num 2, pp 148-151, issn 0736-6205Article
Regulatory requirements for licensing medicinal products of biotechnologyDUNCAN, M. E; CHARLESWORTH, F. A; GRIFFIN, J. P et al.Trends in biotechnology (Regular ed.). 1987, Vol 5, Num 12, pp 325-328, issn 0167-7799Article
Highly sensitive flow injection analysis of glucose and uric acid in serum using an immobilized enzyme column and cheluminescenceTABATA, M; FUKUNAGA, C; OHYABU, M et al.Journal of applied biochemistry. 1984, Vol 6, Num 4, pp 251-258, issn 0161-7354Article
A simple inulin assay for renal clearance determination using an immobilized β-fructofuranosidaseDAY, D. F; WORKMAN, W. E.Annals of the New York Academy of Sciences. 1984, Vol 434, pp 504-507, issn 0077-8923Conference Paper
Current status of activity assays for tissue plasminogen activatorTANG, J. C.-T; LI, S; MCGRAY, P et al.Annals of the New York Academy of Sciences. 1984, Vol 434, pp 536-540, issn 0077-8923Conference Paper
Genex gets two extensions on therapeutic research fundsGenetic engineering news. 1983, Vol 3, Num 5, 17Article
Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viabilityKORICH, D. G; MEAD, J. R; MADORE, M. S et al.Applied and environmental microbiology (Print). 1990, Vol 56, Num 5, pp 1423-1428, issn 0099-2240Article
The in vitro bioassay of hormones using cultured mammalian cellsBIDEY, S. P.Journal of biotechnology. 1988, Vol 7, Num 4, pp 259-269, issn 0168-1656Article
Les biotechnologies dans le domaine médical. Quelques exemples: leurs implications sur les stratégies de santé = Biotechnology in medicine. A few examples and their implications on health strategiesDIXSAUT, G.RBM. Revue européenne de biotechnologie médicale. 1988, Vol 10, Num 2, pp 104-107, issn 0222-0776Article
Microbial DNA diagnostic technologyPASTERNAK, J. J.Biotechnology advances. 1988, Vol 6, Num 4, pp 683-695, issn 0734-9750Article
The determination of low levels of aluminum in antihemophilic factor (human) preparations by flame atomic absorption spectrometryPROGAR, J. J; MAY, J. C.Journal of biological standardization. 1988, Vol 16, Num 2, pp 119-127, issn 0092-1157Article
Biotechnology in Livestock productionREED, D. E.A.C.S. symposium series. 1988, Num 362, pp 307-311, issn 0097-6156Conference Paper
Etat actuel et perspectives de la biocatalyse dans la production d'antibiotiques β-lactanesBARTOSHEVICH, YU. EH; NYS, P. S; SHVYADAS, V.-YU. K et al.Antibiotiki i medicinskaâ biotehnologiâ. 1986, Vol 31, Num 2, pp 98-104, issn 0233-7525Article
Genetic engineering in bacteria and its application to health care productsMURRAY, K.International conference on the commercial applications and implications of biotechnology. 1. 1983, pp 381-388Conference Paper
Immunocomb: a novel concept in immunological diagnosis of viral and parasitic diseasesRITTERBAND, M; RIVETZ, B; SAMUELS, F et al.Chimica oggi. 1990, Vol 8, Num 1-2, pp 25-31, issn 0392-839XArticle
Parasitic hazard with sewage sludge applied to landBARBIER, D; PERRINE, D; DUHAMEL, C et al.Applied and environmental microbiology (Print). 1990, Vol 56, Num 5, pp 1420-1422, issn 0099-2240Article
Contribution of genetics to the production and discovery of microbial pharmaceuticalsDEMAIN, A. L.Pure and applied chemistry. 1988, Vol 60, Num 6, pp 833-836, issn 0033-4545Conference Paper
Tverdofaznyj immunofermentnyj analiz insulina s ispol'zovanien β-laktamazy iz Bacillus licheniformis 749/c i peroksidazy khrena v kachestve markerovZHVIRBLENE, A; NOREJKA, R.-K. M; SAZYKIN, A. YU et al.Antibiotiki i medicinskaâ biotehnologiâ. 1987, Vol 32, Num 4, pp 279-282, issn 0233-7525Article
Process technologies for in vitro production of retrovirus and monoclonal antibody for use as anticancer biologicsFLICKINGER, M. C; LEBHERZ, W. B. III; LEE, S.-M et al.Developments in industrial microbiology. 1987, Vol 27, pp 87-99, issn 0070-4563Conference Paper